Please login to the form below

Not currently logged in
Email:
Password:

Icon

This page shows the latest Icon news and features for those working in and with pharma, biotech and healthcare.

Yale Cancer Center joins BMS’ II-ON

Yale Cancer Center joins BMS’ II-ON

Oncology Network (IO-ICON) and the Oncology Academic Research Group (OAR).

Latest news

  • Lilly pilots enhanced online trial information Lilly pilots enhanced online trial information

    Approaching this issue Lilly's Naas explained: “ We tried to avoid using complex medical terms and jargon and opted instead to illustrate study procedures using icons and symbols rather than words. “

  • ICON boosts leadership teams ICON boosts leadership teams

    ICON boosts leadership teams. Dr Andrew Garrett, Dr Paul McCracken and Jim Carroll join. ... Pharmaceutical service provider ICON has boosted its scientific operations, medical imaging and real world evidence leadership teams with three new senior

  • Paywatch and the market access waters Paywatch and the market access waters

    to market access,” says James Eaton, principal, health economics, ICON Commercialisation &Outcomes. “ ... A good partner can predict exactly how payers will react to particular trial designs or product profiles,” says Catherine Beecher, principal,

  • IBM adds to healthcare capabilities with Truven buy IBM adds to healthcare capabilities with Truven buy

    and a clinical trial recruitment collaboration with ICON.

  • Less is more: how risk-based monitoring is changing trials Less is more: how risk-based monitoring is changing trials

    We are encouraging our customers to move to the more patient-centric risk-based approach,” says Steven Cutler, chief operating officer of ICON, who indicated that interest in RBM is growing ... It's certainly moving faster than electronic data capture

More from news
Approximately 7 fully matching, plus 37 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 3 fully matching, plus 4 partially matching documents found.

Latest appointments

  • RJW & Partners appoints new director RJW & Partners appoints new director

    RJW &Partners appoints new director. Cathy Beecher joins from ICON. Pricing and market access group RJW &Partners, a subsidiary of Mission Group, has appointed Cathy Beecher as its new director. ... She joins the firm from pharma service provider ICON,

  • PharmaLex strengthens international team PharmaLex strengthens international team

    He joins the group from ICON, where he was vice president, global business development early phase services.

  • Teckro appoints Dana Poff as COO Teckro appoints Dana Poff as COO

    Teckro appoints Dana Poff as COO. She joins the Irish group from ICON. ... Poff joins the Limerick, Ireland-based group from ICON, a clinical research organisation, where she held leadership roles in clinical operations, project management and alliance

  • PharmaLex Group strengthens development consulting team PharmaLex Group strengthens development consulting team

    Most recently, Belcher served as head of global regulatory affairs at ICON, having been promoted from vice president in 2014.

  • Quanticate names chief operating officer Quanticate names chief operating officer

    Previously, Morgan served as ICON's group president for clinical research services, and has held a number of finance management roles atMDS and RPS.

More from appointments
Approximately 7 fully matching, plus 11 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Makara Health

Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...

Infographics